KRChoksey is bullish on Dr Reddys Laboratories (DRL) and has recommended accumulate rating on the stock with a target price of Rs 3957 in its research report dated May 13, 2015.

Alpha Trade: Long Dr Reddy`s, short Nifty, says ICICIdirect

ICICIdirect.com has come out with its alpha trading strategy report. The research firm has advised to buy 1 lot of Dr Reddy's April future at Rs 3515-3525 and sell 2 lots of Nifty April future at 8660-8680, in its research report dated March 24, 2015.

Buy Dr Reddys Laboratories; target of Rs 3878: Angel

Angel Broking is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target of Rs 3,878 in its February 02, 2015 research report.

Accumulate Dr Reddys; target Rs 3662: Kotak Sec

Kotak Securities is bullish on Dr Reddys Laboratories and has recommended accumulate rating on the stock with a target price of Rs 3662, in its research report dated January 30, 2015.

Buy Dr Reddys Labs; target of Rs 3684: Emkay

Brokerage house Emkay Global Financial Services is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 3684, in its research report dated January 29, 2015.

Accumulate Dr Reddys; target of Rs 3368: P Lilladher

Brokerage house Prabhudas Lilladher is bullish on Dr Reddys Laboratories and has recommended 'Accumulate' rating on the stock with a target price of Rs 3368, in its research report dated January 30, 2015.

Accumulate Dr Reddys Labs; target Rs 3722: KRChoksey

KRChoksey is bullish on Dr Reddys Laboratories and has recommended accumulate rating on the stock with a target price of Rs 3,722 in its January 29, 2015 research report.

Buy Dr Reddys Labs; target of Rs 3750: Angel Broking

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 3750 in its October 30, 2014 research report.

Accumulate Dr Reddys Labs; target of Rs 3485: KRChoksey

KRChoksey is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 3485 in its October 30, 2014 research report.

Buy Dr Reddys Labs; target of Rs 3399: Angel Broking

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 3399 in its May 14, 2014 research report.

Buy Dr Reddys Laboratories; target Rs 3180: Motilal Oswal

Brokerage house Motilal Oswal is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 3180, in its research report dated March 10, 2014.

Buy Dr Reddys Laboratories; target of Rs 3239: ICICIdirect

ICICIdirect.com is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target price of Rs 3239, in its research report dated March 06, 2014.

Buy Dr Reddys Laboratories; target of Rs 2995: ICICIdirect

ICICIdirect.com is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 2995, in its research report dated February 17, 2014.

Buy Dr Reddys Labs; target Rs 2404: Firstcall Research

Brokerage house Firstcall Research is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 2404 in its August 07, 2013 research report.

Accumulate Dr Reddys Laboratories; target Rs 2532: Angel

Brokerage house Angel Broking is bullish on Dr Reddys Laboratories and has recommended 'Accumulate' rating on the stock with a price target of Rs 2,532 in its research report dated August 1, 2013.

Buy Dr Reddys Laboratories; target Rs 2280: AnandRathi

AnandRathi is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target of Rs 2,280.

Hold Dr Reddys Laboratories: Ventura Securities

Ventura Securities has recommended hold rating on Dr Reddy Laboratories (DRL), in its February 21, 2013 research report. The research firm, expects company's performance in FY14 to remain muted and restricted to single digit growth.

Angel Broking neutral on Dr Reddys Laboratories

Angel Broking has maintained a neutral rating on Dr Reddys Laboratories (DRL) in its February 21, 2013 research report. The research firm expects net sales to report a 9.8% CAGR to Rs 11,662cr and adjusted EPS to record a 2.3% CAGR to Rs 92.9 over FY2012-14E.

Hold Dr Reddys Labs; target Rs 2050: Firstcall Research

Firstcall Research has recommended hold rating on Dr Reddys Laboratories with a target price of Rs 2050, in its February 20, 2013 research report.

Buy Dr Reddys Labs; target of Rs 2161: PLilladher

Prabhudas Lilladher is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2161 in its February 15, 2013 research report.

Accumulate Dr Reddys Labs; target of Rs 2055: Dolat Capital

Dolat Capital is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 2055 in its February 15, 2013 research report.

Buy Dr Reddys Labs; target of Rs 2425: Motilal Oswal

Motilal Oswal is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2425 in its February 12, 2013 research report.

10 largecap top investment ideas for 2013: Emkay

Emkay Global Financial Services has come out with its report on conviction ideas.

Buy Dr Reddys Labs; target of Rs 2250: Emkay

Emkay Gobal Financial Services is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2250 in its January 1, 2013 research report.

Buy Dr Reddys Labs on dip; target Rs 2150-2320: AnandRathi

AnandRathi is bullish on Dr Reddys Labs and has recommended to buy the stock on dips for the targets of Rs 2150-2320 in its December 27, 2012 research report.